A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonate-Reference-Cited by-同舟云学术

A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonate

Published:1991-09 Issue:9 Volume:27 Page:1084-1086
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Turner J.Harvey,Claringbold Phillip G.

Publisher

Elsevier BV

Subject

Oncology

Reference8 articles.

1. New agents and new medical treatments for advanced breast cancer;Henderson;Semin Oncol,1987

2. Systemic radioisotopic therapy of primary and metastatic bone cancer;Robinson;J Nucl Med,1990

3. Samarium-153 EDTMP therapy of disseminated skeletal metastasis;Turner;Eur J Nucl Med,1989

4. A phase I study of samarium-153 ethylenediametetramethylene phosphonate therapy for disseminated skeletal metastases;Turner;J Clin Oncol,1989

5. Eary JF, Collins C, Nemiroff C, et al. Single dose Samarium-153 EDTMP treatment in prostate carcinoma. J Nucl Med (in press).

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Radiopharmaceutical Therapy for Bone Metastases;Seminars in Nuclear Medicine;2024-07

2. Bone Metastases;Oncologic Imaging : a Multidisciplinary Approach;2023

3. Targeted Radionuclide Therapy for Bone Metastasis;Nuclear Oncology;2022

4. THERAGNOSTICS OF SAMARIUM-153-EDTMP IN PATIENTS BEARING PROSTATE CANCER AND OSSEOUS SECONDARIES: PALLIATIVE BUT ALSO TUMOURICIDAL;INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH;2022-01-01

5. Targeted Radionuclide Therapy for Bone Metastasis;Nuclear Oncology;2022